UK medicine regulator looking at capillary leak syndrome precaution for AstraZeneca shot

Stock Markets42 minutes ago (Jun 11, 2021 10:23AM ET)

(C) Reuters. FILE PHOTO: A vial of AstraZeneca coronavirus vaccine is seen at a vaccination centre in Westfield Stratford City shopping centre, amid the outbreak of coronavirus disease (COVID-19), in London, Britain, February 18, 2021. REUTERS/Henry Nicholls

LONDON (Reuters) – Britain’s MHRA medicine regulator is considering precautionary advice for people with a history of capillary leak syndrome but does not see a causal link with AstraZeneca (NASDAQ:AZN)’s COVID-19 vaccine after the EU said it was a rare side effect of the shot.

MHRA Chief Executive June Raine said that two of eight reports of capillary leak syndrome following AstraZeneca vaccination were in people with a history of the condition, and 40 million doses of the vaccine had been given.

“The incidence of these reports is lower than the number of cases expected to occur by chance in the absence of vaccination of this extremely rare condition and the current evidence does not suggest that capillary leak syndrome is caused by the COVID-19 Vaccine AstraZeneca,” she said.

“Whether or not a precautionary advice is warranted for patients who have previously experienced capillary leak syndrome is currently being carefully considered by the MHRA as well as the independent Commission on Human Medicines’ COVID-19 Benefit/Risk Expert Working Group.”

UK medicine regulator looking at capillary leak syndrome precaution for AstraZeneca shot

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Stories

Discover

‘Whatever it takes’, UK’s Johnson warns EU over post-Brexit...

World7 minutes ago (Jun 12, 2021 09:57AM ET) 2/2 (C) Reuters. Britain's Prime Minister Boris Johnson...

Toshiba board to hold emergency meeting on Sunday, sources...

Stock Markets40 minutes ago (Jun 12, 2021 09:25AM ET) (C) Reuters. FILE PHOTO: The logo...

Chile shuts capital Santiago once more as vaccines fail...

World49 minutes ago (Jun 12, 2021 09:15AM ET) (C) Reuters. FILE PHOTO: A woman walks...

UBS investment makes Byju’s the most valuable startup in...

Edtech giant Byju’s has become the most valuable startup in India after raising about...

U.S. screens 2.02 million airport passengers Friday – highest...

Stock Markets11 minutes ago (Jun 12, 2021 08:55AM ET) (C) Reuters. FILE PHOTO: Travelers go...

Exclusive-Macron offers UK’s Johnson ‘Le reset’ if he keeps...

Forex10 minutes ago (Jun 12, 2021 04:55AM ET) (C) Reuters. Britain's Prime Minister Boris Johnson...

Popular Categories